Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
N/A
-10,890 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
N/A
-10,987 Reduced 50.22%
10,890 $0
Q1 2021

May 17, 2021

SELL
N/A
-106,916 Reduced 83.01%
21,877 $68,000
Q4 2020

Feb 16, 2021

BUY
N/A
111,228 Added 633.24%
128,793 $560,000
Q3 2020

Nov 16, 2020

SELL
N/A
-24,118 Reduced 57.86%
17,565 $76,000
Q2 2020

Aug 14, 2020

BUY
N/A
19,699 Added 89.61%
41,683 $224,000
Q1 2020

May 15, 2020

BUY
N/A
2,600 Added 13.41%
21,984 $80,000
Q2 2019

Aug 14, 2019

SELL
N/A
-16,272 Reduced 45.64%
19,384 $145,000
Q3 2018

Nov 13, 2018

BUY
N/A
17,881 Added 100.6%
35,656 $0
Q2 2018

Aug 10, 2018

SELL
N/A
-642 Reduced 3.49%
17,775 $0
Q1 2018

May 11, 2018

BUY
N/A
18,417 New
18,417 $28,000

About Chiasma, Inc.


  • Ticker CHMA
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,843,600
  • Market Cap $238M
More about CHMA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.